Biomunex SAT cell engagersFrench Ipsen inks US$610m biobucks deal...French Ipsen has exclusively licensed BMX-502, a T-cell engager (TCE) from Biommunex SA, which prevents common problems of TCEs such as cytokine release syndrome and T cell exhaustion by using a specific … more ➔
Resalis Therapeutics srlObesityObesity gene therapy enters Phase I test...After securing an equity investment from French pharma giant Sanofi, Italian gene therapy company Resalis Therapeutics srl has begun enrolling participants for a Phase I study of its obesity gene therapy, … more ➔
SLASAutomation & Drug ScreeningEuropean Biotechnology and SLAS seal par...The Society for Laboratory Automation & Screening (SLAS) has selected the European Biotechnology Magazine as its official media partner. more ➔
Science, www.science.org/doi/10.1126/sciadv.adn8662Environmental researchBreakthrough: Bio-based foam absorbs 99%...Chinese researchers headed by Prof. Dr. Hongbing Deng from Wuhan University report they were able to absorb up to 99.9% of microplastics in water, which could help solve one of the most pressing environmental … more ➔
Cradle.bioFinancingCradle Secures $73m Series B to Accelera...The Dutch-Swiss company with operations also in Zurich, Switzerland, has raised US$73m in a Series B and will continue to expand its AI research, sales, and operations teams. The new announcement comes … more ➔
Roche, Herzog&De MeuronM&ARoche makes takeover bid for Poseida The...Genentech, the US arm of Swiss-based Roche AG, plans to acquire its long-time partner in allogeneic CAR-T blood cancer and gene therapies, Poseida Therapeutics Inc, for up to US$1.5bn. more ➔
PharmaMar SAMarket AuthorisationEC ordered to pay cost of PharmaMar vs E...The General Court of the EU orders the European Commission to pay the costs in the case of Aplidin® against the Spanish company PharmaMar SA, in which an EU marketing authorisation was not granted due … more ➔
NOD-Proteindesign.Andreas Heddergott/TUM.jpgProtein EngineeringNew method set to speed up protein designResearcher from China, Germany and the US have developed a method for designing large new proteins with pre-defined properties in the lab using Alphafold2. more ➔
CertestDrug deliveryCircio Holding ASA inks collaboration ag...Circio Holding ASA has inked a collaboration with Certest Biotec, SL to find and test circVec LNP-formulations to deliver its circular RNA therapeutics to target tissues for gene therapies. more ➔
ConsiliumNovel FoodCountry alliance calls for EU protein s...A dispute is brewing in Europe over climate-friendly protein production in fermenters between EU member states that are in favour of or against protein production independent of agricultural land. Germany, … more ➔
Biomunex SA
Resalis Therapeutics srl
SLAS
Science, www.science.org/doi/10.1126/sciadv.adn8662
Cradle.bio
Roche, Herzog&De Meuron
PharmaMar SA
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium